Related Experiment Video
Updated: Sep 13, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes Mellitus: A Randomized Controlled
Amy M Valent1, Michaela Rickert1, Christian Huerta Pagan1
1School of Medicine, Department of Obstetrics & Gynecology, Division Maternal-Fetal Medicine, Oregon Health & Science University, Portland, OR.
Real-time continuous glucose monitoring (CGM) significantly improved glucose time in range for pregnant individuals with gestational diabetes mellitus (GDM). This advanced monitoring method offers better glycemic control compared to traditional capillary blood glucose testing.
Area of Science:
- Endocrinology
- Maternal-Fetal Medicine
- Medical Technology
Background:
- Gestational diabetes mellitus (GDM) requires careful glucose monitoring during pregnancy.
- Traditional capillary blood glucose (CBG) monitoring may not provide a comprehensive glycemic picture.
- Real-time continuous glucose monitoring (CGM) offers continuous data for improved management.
Purpose of the Study:
- To compare the efficacy of real-time CGM versus CBG monitoring in achieving target glucose time in range (%TIR) in pregnant individuals with GDM.
- To evaluate the impact of CGM on glycemic control metrics in GDM pregnancies.
Main Methods:
- An open-label, single-center randomized controlled trial was conducted.
- Pregnant individuals with GDM were randomized (2:1) to either real-time CGM plus CBG or CBG alone.
- The primary outcome was %TIR (60-140 mg/dL) from enrollment to delivery.
Main Results:
- The CGM group achieved a significantly higher %TIR (93% ± 6) compared to the CBG group (88% ± 14; P = 0.027).
- The intervention group demonstrated higher daytime TIR and lower mean 24-h and daytime glucose levels.
- Fewer participants in the CGM group experienced time above 140 mg/dL.
Conclusions:
- Real-time CGM significantly increases %TIR in pregnant individuals with GDM compared to CBG monitoring.
- Further research is warranted to ascertain if improved CGM-derived glucose levels impact perinatal and neonatal outcomes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon

